Associated Papers
Circulating cell-free DNA profiling reveals ancestry-dependent genetic variation in metastatic prostate cancer.
Maleknia S et al.
Molecular Biomedicine, 2026
41673362 (PubMed )
Supplement: 43556_2026_405_MOESM2_ESM.xlsx › cfDNA_Variants
Post-GWAS in prostate cancer: from genetic association to biological contribution.
Farashi S et al.
Nature Reviews. Cancer, 2019
Mutations in the prostate specific antigen (PSA/KLK3) correlate with male infertility.
Gupta N et al.
Scientific Reports, 2017
Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer.
Hoffmann TJ et al.
Nature Communications, 2017
Characterization of the Glycosylation Site of Human PSA Prompted by Missense Mutation using LC-MS/MS.
Song E et al.
Journal of Proteome Research, 2015
Very low PSA concentrations and deletions of the KLK3 gene.
Rodriguez S et al.
Clinical Chemistry, 2013
Presence of antigen-specific somatic allelic mutations and splice variants do not predict for immunological response to genetic vaccination.
Becker JT et al.
Journal for Immunotherapy of Cancer, 2013
A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.
Parikh H et al.
Human Genetics, 2010
19823874 (PubMed )
Supplement: 439_2009_751_MOESM5_ESM.pdf
The interaction of CYP3A5 polymorphisms along the androgen metabolism pathway in prostate cancer.
Vaarala MH et al.
International Journal of Cancer, 2008
Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.
Mononen N et al.
Cancer Research, 2006
Select a paper to view details